DIVISLAB's weekly performance was disappointing, with a -3.31% return, underperforming its peers. The stock's high volatility of 24.86% contributed to its poor performance, making it a risky investment this week. Compared to its peers, DIVISLAB's return was the lowest, and its Sharpe Ratio was only slightly better than DRREDDY and SUNPHARMA. Overall, the stock's performance was lackluster, and investors should exercise caution.

[Volatility: 24.86%]